Spector BD, Perry GS III, Kersey JH. Genetically determined immunodeficiency diseases (GDID) and malignancy: report from the immunodeficiency--cancer registry. Clin Immunol Immunopathol. 1978 Sep. 11(1):12-29. [QxMD MEDLINE Link].
Dronca RS, Jevremovic D, Hanson CA, Rabe KG, Shanafelt TD, Morice WG, et al. CD5-positive chronic B-cell lymphoproliferative disorders: diagnosis and prognosis of a heterogeneous disease entity. Cytometry B Clin Cytom. 2010. 78 Suppl 1:S35-41. [QxMD MEDLINE Link]. [Full Text].
Sciallis AP, Law ME, Inwards DJ, McClure RF, Macon WR, Kurtin PJ, et al. Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders. Mod Pathol. 2012 Mar 2. [QxMD MEDLINE Link].
Engel P, Eck MJ, Terhorst C. The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease. Nat Rev Immunol. 2003 Oct. 3(10):813-21. [QxMD MEDLINE Link].
Latour S. Natural killer T cells and X-linked lymphoproliferative syndrome. Curr Opin Allergy Clin Immunol. 2007 Dec. 7(6):510-4. [QxMD MEDLINE Link].
Worth A, Thrasher AJ, Gaspar HB. Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype. Br J Haematol. 2006 Apr. 133(2):124-40. [QxMD MEDLINE Link].
Kaplan J, De Domenico I, Ward DM. Chediak-Higashi syndrome. Curr Opin Hematol. 2008 Jan. 15(1):22-9. [QxMD MEDLINE Link].
Notarangelo LD, Miao CH, Ochs HD. Wiskott-Aldrich syndrome. Curr Opin Hematol. 2008 Jan. 15(1):30-6. [QxMD MEDLINE Link].
Boztug K, Schmidt M, Schwarzer A, Banerjee PP, Díez IA, Dewey RA, et al. Stem-cell gene therapy for the Wiskott-Aldrich syndrome. N Engl J Med. 2010 Nov 11. 363(20):1918-27. [QxMD MEDLINE Link]. [Full Text].
Ishihara D, Dovas A, Park H, Isaac BM, Cox D. The chemotactic defect in wiskott-Aldrich syndrome macrophages is due to the reduced persistence of directional protrusions. PLoS One. 2012. 7(1):e30033. [QxMD MEDLINE Link]. [Full Text].
Houshmand M, Kasraie S, Etemad Ahari S, Moin M, Bahar M, Zamani A. Investigation of tRNA and ATPase 6/8 gene mutations in Iranian ataxia telangiectasia patients. Arch Med Sci. 2011 Jun. 7(3):523-7. [QxMD MEDLINE Link]. [Full Text].
Absalon MJ, Khoury RA, Phillips CL. Post-transplant lymphoproliferative disorder after solid-organ transplant in children. Semin Pediatr Surg. 2017 Aug. 26 (4):257-266. [QxMD MEDLINE Link].
Ohta H, Fukushima N, Ozono K. Pediatric post-transplant lymphoproliferative disorder after cardiac transplantation. Int J Hematol. 2009 Sep. 90(2):127-36. [QxMD MEDLINE Link].
Weintraub L, Weiner C, Miloh T, Tomaino J, Joashi U, Benchimol C, et al. Identifying predictive factors for posttransplant lymphoproliferative disease in pediatric solid organ transplant recipients with epstein-barr virus viremia. J Pediatr Hematol Oncol. 2014 Nov. 36(8):e481-6. [QxMD MEDLINE Link].
Baehner RL. Lymphocytes. Miller DR, Baehner RL, eds. Blood Diseases in Infancy and Childhood. St. Louis, MO: CV Mosby; 1990. 578-603.
Bird AG, Britton S. The relationship between Epstein-Barr virus and lymphoma. Semin Hematol. 1982 Oct. 19(4):285-300. [QxMD MEDLINE Link].
Brusamolino E, Pagnucco G, Bernasconi C. Secondary lymphomas: a review on lymphoproliferative diseases arising in immunocompromised hosts: prevalence, clinical features and pathogenetic mechanisms. Haematologica. 1989 Nov-Dec. 74(6):605-22. [QxMD MEDLINE Link].
Certain S, Barrat F, Pastural E, et al. Protein truncation test of LYST reveals heterogenous mutations in patients with Chediak-Higashi syndrome. Blood. 2000 Feb 1. 95(3):979-83. [QxMD MEDLINE Link].
Craig FE, Gulley ML, Banks PM. Posttransplantation lymphoproliferative disorders. Am J Clin Pathol. 1993 Mar. 99(3):265-76. [QxMD MEDLINE Link].
Fiorilli M, Carbonari M, Crescenzi M, et al. T-cell receptor genes and ataxia telangiectasia. Nature. 1985 Jan 17-23. 313(5999):186. [QxMD MEDLINE Link].
Kempf W. CD30+ lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulators. J Cutan Pathol. 2006 Feb. 33 Suppl 1:58-70. [QxMD MEDLINE Link].
Locker J, Nalesnik M. Molecular genetic analysis of lymphoid tumors arising after organ transplantation. Am J Pathol. 1989 Dec. 135(6):977-87. [QxMD MEDLINE Link].
Loughrey M, Trivett M, Lade S, et al. Diagnostic application of Epstein-Barr virus-encoded RNA in situ hybridisation. Pathology. 2004 Aug. 36(4):301-8. [QxMD MEDLINE Link].
Lundell R, Elenitoba-Johnson KS, Lim MS. T-cell posttransplant lymphoproliferative disorder occurring in a pediatric solid-organ transplant patient. Am J Surg Pathol. 2004 Jul. 28(7):967-73. [QxMD MEDLINE Link].
Marti GE, Rawstron AC, Ghia P, et al. Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol. 2005 Aug. 130(3):325-32. [QxMD MEDLINE Link].
Nichols KE. X-linked lymphoproliferative disease: genetics and biochemistry. Rev Immunogenet. 2000. 2(2):256-66. [QxMD MEDLINE Link].
Rigaud S, Fondaneche MC, Lambert N, et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature. 2006 Nov 2. 444(7115):110-4. [QxMD MEDLINE Link].
Sanal O, Wei S, Foroud T, et al. Further mapping of an ataxia-telangiectasia locus to the chromosome 11q23 region. Am J Hum Genet. 1990 Nov. 47(5):860-6. [QxMD MEDLINE Link].
Sander CA, Medeiros LJ, Weiss LM, et al. Lymphoproliferative lesions in patients with common variable immunodeficiency syndrome. Am J Surg Pathol. 1992 Dec. 16(12):1170-82. [QxMD MEDLINE Link].
Snyder MJ, Stenzel TT, Buckley PJ, et al. Posttransplant lymphoproliferative disorder following nonmyeloablative allogeneic stem cell transplantation. Am J Surg Pathol. 2004 Jun. 28(6):794-800. [QxMD MEDLINE Link].
Straus SE, Sneller M, Lenardo MJ, et al. An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome. Ann Intern Med. 1999 Apr 6. 130(7):591-601. [QxMD MEDLINE Link].
Su HC, Lenardo MJ. Genetic defects of apoptosis and primary immunodeficiency. Immunol Allergy Clin North Am. 2008 May. 28(2):329-51, ix. [QxMD MEDLINE Link].
Uzel G. The range of defects associated with nuclear factor kappaB essential modulator. Curr Opin Allergy Clin Immunol. 2005 Dec. 5(6):513-8. [QxMD MEDLINE Link].
Vetrie D, Vorechovsky I, Sideras P, et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature. 1993 Jan 21. 361(6409):226-33. [QxMD MEDLINE Link].
Chandrakasan S, Chandra S, Davila Saldana BJ, Torgerson TR, Buchbinder D. Primary immune regulatory disorders for the pediatric hematologist and oncologist: A case-based review. Pediatr Blood Cancer. 2019 Jan 29. e27619. [QxMD MEDLINE Link].
Yachie A. Cytologic Analysis of Epstein-Barr Virus-Associated T/Natural Killer-Cell Lymphoproliferative Diseases. Front Pediatr. 2018. 6:327. [QxMD MEDLINE Link].